REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 160 filers reported holding REVANCE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 2.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,671,094 | -10.4% | 1,366,268 | +97.8% | 0.05% | -11.5% |
| Q2 2023 | $17,484,983 | +3669.7% | 690,833 | +4697.5% | 0.05% | +5100.0% |
| Q1 2023 | $463,824 | -94.5% | 14,400 | -97.6% | 0.00% | -97.1% |
| Q2 2022 | $8,369,000 | -45.5% | 605,574 | -23.0% | 0.04% | -42.6% |
| Q1 2022 | $15,346,000 | +6.7% | 786,967 | -10.7% | 0.06% | +7.0% |
| Q4 2021 | $14,386,000 | -31.6% | 881,482 | +16.8% | 0.06% | -38.0% |
| Q3 2021 | $21,029,000 | +180.3% | 754,800 | +181.2% | 0.09% | +162.9% |
| Q1 2021 | $7,502,000 | +74.3% | 268,400 | +1.2% | 0.04% | +52.2% |
| Q4 2019 | $4,304,000 | +51.8% | 265,199 | +21.6% | 0.02% | +35.3% |
| Q3 2019 | $2,836,000 | +88.9% | 218,155 | +88.6% | 0.02% | +112.5% |
| Q2 2019 | $1,501,000 | – | 115,700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NovaQuest Capital Management, L.L.C. | 1,558,426 | $48,000,000 | 65.50% |
| Essex Woodlands Management, Inc. | 3,842,047 | $118,335,000 | 25.90% |
| Rhenman & Partners Asset Management AB | 203,181 | $6,258,000 | 0.77% |
| EAM Global Investors LLC | 44,898 | $1,383,000 | 0.72% |
| Fosun International Ltd | 319,313 | $9,835,000 | 0.62% |
| EAM Investors, LLC | 113,096 | $3,483,000 | 0.58% |
| ArrowMark Colorado Holdings LLC | 1,735,699 | $53,460,000 | 0.53% |
| Perceptive Advisors | 618,957 | $19,064,000 | 0.53% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 111,360 | $3,430,000 | 0.45% |
| Schonfeld Strategic Advisors LLC | 83,700 | $2,578,000 | 0.19% |